vs
CULP INC（CULP）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
CULP INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.5倍（$53.2M vs $35.5M），CULP INC净利率更高（-8.1% vs -304.2%，领先296.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -4.4%），CULP INC自由现金流更多（$-510.0K vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -6.2%）
Culp Inc是全球领先的纺织品制造商，主营住宅及商用家具装饰面料、床垫面料产品，为家具生产商、床上用品供应商提供配套原材料，业务覆盖北美、亚洲、欧洲等主要市场。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CULP vs RXRX — 直观对比
营收规模更大
CULP
是对方的1.5倍
$35.5M
营收增速更快
RXRX
高出686.2%
-4.4%
净利率更高
CULP
高出296.1%
-304.2%
自由现金流更多
CULP
多$46.8M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $53.2M | $35.5M |
| 净利润 | $-4.3M | $-108.1M |
| 毛利率 | 10.9% | 59.8% |
| 营业利润率 | -6.5% | -304.8% |
| 净利率 | -8.1% | -304.2% |
| 营收同比 | -4.4% | 681.7% |
| 净利润同比 | 23.7% | 39.6% |
| 每股收益（稀释后） | $-0.34 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CULPRXRX
| Q4 25 | $53.2M | $35.5M | ||
| Q3 25 | $50.7M | $5.2M | ||
| Q2 25 | $48.8M | $19.2M | ||
| Q1 25 | $52.3M | $14.7M | ||
| Q4 24 | $55.7M | $4.5M | ||
| Q3 24 | $56.5M | $26.1M | ||
| Q2 24 | $49.5M | $14.4M | ||
| Q1 24 | $60.4M | $13.8M |
净利润CULPRXRX
| Q4 25 | $-4.3M | $-108.1M | ||
| Q3 25 | $-231.0K | $-162.3M | ||
| Q2 25 | $-2.1M | $-171.9M | ||
| Q1 25 | $-4.1M | $-202.5M | ||
| Q4 24 | $-5.6M | $-178.9M | ||
| Q3 24 | $-7.3M | $-95.8M | ||
| Q2 24 | $-4.9M | $-97.5M | ||
| Q1 24 | $-3.2M | $-91.4M |
毛利率CULPRXRX
| Q4 25 | 10.9% | 59.8% | ||
| Q3 25 | 14.3% | -183.8% | ||
| Q2 25 | 15.7% | -4.9% | ||
| Q1 25 | 12.1% | -48.0% | ||
| Q4 24 | 10.8% | -181.4% | ||
| Q3 24 | 9.0% | 53.7% | ||
| Q2 24 | 10.5% | 36.2% | ||
| Q1 24 | 12.7% | 19.1% |
营业利润率CULPRXRX
| Q4 25 | -6.5% | -304.8% | ||
| Q3 25 | 3.2% | -3327.6% | ||
| Q2 25 | -4.6% | -916.8% | ||
| Q1 25 | -7.4% | -1297.9% | ||
| Q4 24 | -9.7% | -4042.4% | ||
| Q3 24 | -12.1% | -377.1% | ||
| Q2 24 | -8.6% | -697.4% | ||
| Q1 24 | -2.9% | -698.4% |
净利率CULPRXRX
| Q4 25 | -8.1% | -304.2% | ||
| Q3 25 | -0.5% | -3135.3% | ||
| Q2 25 | -4.2% | -894.2% | ||
| Q1 25 | -7.9% | -1373.3% | ||
| Q4 24 | -10.1% | -3935.5% | ||
| Q3 24 | -12.8% | -367.5% | ||
| Q2 24 | -9.8% | -676.6% | ||
| Q1 24 | -5.3% | -662.4% |
每股收益（稀释后）CULPRXRX
| Q4 25 | $-0.34 | $-0.17 | ||
| Q3 25 | $-0.02 | $-0.36 | ||
| Q2 25 | $-0.17 | $-0.41 | ||
| Q1 25 | $-0.33 | $-0.50 | ||
| Q4 24 | $-0.45 | $-0.56 | ||
| Q3 24 | $-0.58 | $-0.34 | ||
| Q2 24 | $-0.39 | $-0.40 | ||
| Q1 24 | $-0.26 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $53.6M | $1.1B |
| 总资产 | $125.2M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CULPRXRX
| Q4 25 | $10.7M | $743.3M | ||
| Q3 25 | $11.1M | $659.8M | ||
| Q2 25 | $5.6M | $525.1M | ||
| Q1 25 | $5.3M | $500.5M | ||
| Q4 24 | $10.5M | $594.4M | ||
| Q3 24 | $13.5M | $427.6M | ||
| Q2 24 | $10.0M | $474.3M | ||
| Q1 24 | $12.6M | $296.3M |
总债务CULPRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益CULPRXRX
| Q4 25 | $53.6M | $1.1B | ||
| Q3 25 | $57.6M | $1.0B | ||
| Q2 25 | $57.6M | $919.1M | ||
| Q1 25 | $59.6M | $933.9M | ||
| Q4 24 | $63.6M | $1.0B | ||
| Q3 24 | $69.1M | $524.6M | ||
| Q2 24 | $76.1M | $584.4M | ||
| Q1 24 | $80.8M | $401.2M |
总资产CULPRXRX
| Q4 25 | $125.2M | $1.5B | ||
| Q3 25 | $126.4M | $1.4B | ||
| Q2 25 | $123.4M | $1.3B | ||
| Q1 25 | $127.6M | $1.3B | ||
| Q4 24 | $129.0M | $1.4B | ||
| Q3 24 | $129.1M | $726.5M | ||
| Q2 24 | $132.1M | $775.9M | ||
| Q1 24 | $142.0M | $557.8M |
负债/权益比CULPRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-471.0K | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-510.0K | $-47.3M |
| 自由现金流率自由现金流/营收 | -1.0% | -133.1% |
| 资本支出强度资本支出/营收 | 0.1% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-17.8M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CULPRXRX
| Q4 25 | $-471.0K | $-46.1M | ||
| Q3 25 | $-695.0K | $-117.4M | ||
| Q2 25 | $-8.2M | $-76.4M | ||
| Q1 25 | $-6.8M | $-132.0M | ||
| Q4 24 | $-2.4M | $-115.4M | ||
| Q3 24 | $-206.0K | $-59.2M | ||
| Q2 24 | $-2.3M | $-82.2M | ||
| Q1 24 | $-1.5M | $-102.3M |
自由现金流CULPRXRX
| Q4 25 | $-510.0K | $-47.3M | ||
| Q3 25 | $-874.0K | $-117.6M | ||
| Q2 25 | $-8.7M | $-79.6M | ||
| Q1 25 | $-7.7M | $-133.8M | ||
| Q4 24 | $-3.5M | $-116.7M | ||
| Q3 24 | $-707.0K | $-63.8M | ||
| Q2 24 | $-2.7M | $-83.4M | ||
| Q1 24 | $-2.8M | $-109.0M |
自由现金流率CULPRXRX
| Q4 25 | -1.0% | -133.1% | ||
| Q3 25 | -1.7% | -2272.5% | ||
| Q2 25 | -17.9% | -413.9% | ||
| Q1 25 | -14.6% | -907.4% | ||
| Q4 24 | -6.3% | -2567.7% | ||
| Q3 24 | -1.3% | -244.6% | ||
| Q2 24 | -5.5% | -578.5% | ||
| Q1 24 | -4.6% | -789.9% |
资本支出强度CULPRXRX
| Q4 25 | 0.1% | 3.5% | ||
| Q3 25 | 0.4% | 4.7% | ||
| Q2 25 | 1.0% | 16.4% | ||
| Q1 25 | 1.6% | 12.4% | ||
| Q4 24 | 1.9% | 28.6% | ||
| Q3 24 | 0.9% | 17.5% | ||
| Q2 24 | 0.9% | 8.2% | ||
| Q1 24 | 2.1% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CULP
| Bedding Fabrics | $30.8M | 58% |
| Upholstery | $22.4M | 42% |
RXRX
暂无分部数据
